- Home
- GPCR vs MXL Comparison
GPCR vs MXL Comparison
Compare GPCR & MXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- MXL
- Stock Information
- Founded
- GPCR 2016
- MXL 2003
- Country
- GPCR United States
- MXL United States
- Employees
- GPCR N/A
- MXL N/A
- Industry
- GPCR
- MXL Semiconductors
- Sector
- GPCR
- MXL Technology
- Exchange
- GPCR Nasdaq
- MXL Nasdaq
- Market Cap
- GPCR 1.6B
- MXL 1.7B
- IPO Year
- GPCR 2023
- MXL 2010
- Fundamental
- Price
- GPCR $27.06
- MXL $24.05
- Analyst Decision
- GPCR Strong Buy
- MXL Buy
- Analyst Count
- GPCR 7
- MXL 7
- Target Price
- GPCR $81.29
- MXL $24.08
- AVG Volume (30 Days)
- GPCR 1.0M
- MXL 1.3M
- Earning Date
- GPCR 03-07-2025
- MXL 01-29-2025
- Dividend Yield
- GPCR N/A
- MXL N/A
- EPS Growth
- GPCR N/A
- MXL N/A
- EPS
- GPCR N/A
- MXL N/A
- Revenue
- GPCR N/A
- MXL $393,714,000.00
- Revenue This Year
- GPCR N/A
- MXL N/A
- Revenue Next Year
- GPCR N/A
- MXL $24.12
- P/E Ratio
- GPCR N/A
- MXL N/A
- Revenue Growth
- GPCR N/A
- MXL N/A
- 52 Week Low
- GPCR $23.50
- MXL $11.08
- 52 Week High
- GPCR $62.74
- MXL $26.59
- Technical
- Relative Strength Index (RSI)
- GPCR 42.52
- MXL 71.93
- Support Level
- GPCR $23.50
- MXL $19.55
- Resistance Level
- GPCR $27.68
- MXL $21.66
- Average True Range (ATR)
- GPCR 1.71
- MXL 1.32
- MACD
- GPCR 0.20
- MXL 0.19
- Stochastic Oscillator
- GPCR 51.30
- MXL 98.88
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About MXL MaxLinear Inc.
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. MaxLinear's product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices. Customers for MaxLinear include original equipment manufacturers, module makers, and original design manufacturers.